|
Market Closed -
Nasdaq
21:00:00 09/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 81.07 USD | +2.09% |
|
-4.35% | +22.15% |
| 10-30 | DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says | MT |
| 10-30 | UBS Adjusts DexCom Price Target to $107 From $102, Maintains Buy Rating | MT |
Business description: DexCom, Inc.
The United States accounts for 71.5% of net sales.
Number of employees: 11,050
Sales by Activity: DexCom, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Patient Monitoring Equipment | 2.45B | 2.91B | 3.62B | 4.03B | 4.66B |
Geographical breakdown of sales: DexCom, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States (U.S.) | 1.85B | 2.14B | 2.63B | 2.89B | 3.33B |
International | 599M | 768M | 997M | 1.14B | 1.33B |
Executive Committee: DexCom, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Leach
CEO | Chief Executive Officer | 47 | 31/12/2025 |
Jereme Sylvain
DFI | Director of Finance/CFO | 46 | 18/03/2021 |
Stacey Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/2024 |
Michael Brown
CMP | Compliance Officer | 56 | - |
Sean Christensen
IRC | Investor Relations Contact | - | 29/02/2020 |
Composition of the Board of Directors: DexCom, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Sayer
CHM | Chairman | 68 | 29/07/2018 |
Nick Augustinos
BRD | Director/Board Member | 67 | 19/11/2009 |
Jacob Leach
BRD | Director/Board Member | 47 | 31/12/2025 |
Steven Altman
BRD | Director/Board Member | 64 | 06/11/2013 |
Mark Foletta
BRD | Director/Board Member | 65 | 18/11/2014 |
Richard Collins
BRD | Director/Board Member | 69 | 08/03/2017 |
Bridgette Heller
BRD | Director/Board Member | 65 | 12/09/2019 |
Kyle Malady
BRD | Director/Board Member | 59 | 10/10/2020 |
Rimma Driscoll
BRD | Director/Board Member | 53 | 23/08/2023 |
Renée Galá
BRD | Director/Board Member | 54 | 05/03/2025 |
Company details: DexCom, Inc.
Group companies: DexCom, Inc.
| Name | Category and Sector |
|---|---|
Dexcom Operating Ltd.
 Dexcom Operating Ltd. Financial ConglomeratesFinance Functions as an investment holding company |
Financial Conglomerates
|
Other Medical Equipment, Supplies & Distribution
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.09% | -4.35% | +47.40% | -12.26% | 30.24B | |
| +0.53% | +0.32% | -12.54% | +18.13% | 191B | |
| +0.97% | +3.53% | +11.49% | +46.65% | 126B | |
| -0.04% | +6.17% | -8.51% | +20.27% | 124B | |
| -1.29% | +2.09% | -39.67% | +7.55% | 98.14B | |
| +3.66% | +2.34% | -4.14% | +75.67% | 65.98B | |
| +1.59% | +8.38% | +21.04% | -7.32% | 58.63B | |
| +4.53% | +5.21% | -0.25% | +68.75% | 55.67B | |
| +1.42% | -3.69% | -5.94% | +53.59% | 48.78B | |
| 0.00% | +2.31% | +2.89% | -5.73% | 36.03B | |
| Average | +1.34% | +1.70% | +1.17% | +26.53% | 83B | |
| Weighted average by Cap. | +0.97% | +2.28% | -4.45% | +27.58% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- DXCM Stock
- Company DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
